社会ガイド

WHO Guidance on AI in Health

WHO guidance on AI in health emphasizes human rights, safety, transparency, accountability, inclusion, and ongoing evaluation.

  • 3 分で読めます
  • 最終更新日
このページでは3 分で読めます
  1. 概要
  2. ディープダイブ
  3. 戦略的影響
  4. The Future of WHO Guidance on AI in Health
  5. 現実世界の実装
  6. リスクとガードレール
  7. 実装ロードマップ
  8. 探検を続けましょう
  9. よくある質問

概要

These are governance principles, not a product certification or a substitute for local law. Health systems should involve affected people, assess risks through the lifecycle, and ensure that AI supports rather than displaces human decision-making.

ディープダイブ

The World Health Organization’s guidance on ethics and governance of AI for health sets out principles for designing, developing, and using AI in ways that protect people and public interests. Its framework calls for human autonomy, safety and well-being, transparency, responsibility and accountability, inclusion and equity, and responsiveness and sustainability. These principles apply across the lifecycle, from deciding whether AI is appropriate to monitoring how it works in practice. WHO emphasizes that people should remain in control of healthcare systems and medical decisions, and that privacy and confidentiality should be protected. AI should be developed for well-defined use cases, with quality controls and meaningful information about design and limitations. Organizations should establish mechanisms for questioning decisions and redress when people are harmed. Inclusion requires attention to who benefits, who is left out, and how access is distributed. The guidance is normative and does not certify a product or replace national regulation. Health systems can use it to build governance: define accountability, engage patients and health workers, assess bias and safety, protect data, and monitor real-world use. WHO’s later guidance on large multimodal models applies similar principles to generative AI, urging careful evaluation and human oversight. Governance should be adapted to local law and health-system capacity. Consider procurement, workforce effects, and how patients can opt out or ask questions. Assign responsibility for responding when a system behaves unexpectedly.

戦略的影響

リスクと安全性

AI による壊滅的な被害も日常的な被害も、誰がリスクを理解し、誰が行動できるかにかかっています。

より明確な判決

国民と専門家のリテラシーは、強力な安全政策が政治的に可能かどうかを左右します。

誇大広告を打ち破る

明確な説明は、誇大広告、研究室の PR、曖昧な倫理劇場に囚われることを減らします。

The Future of WHO Guidance on AI in Health

WHO and national bodies continue to develop guidance as new AI capabilities enter health systems. More capable generative models increase the importance of measuring benefit before routine use and maintaining privacy, accountability, and human oversight. Health organizations can build trust through transparent limits, community participation, and continuous evaluation. Ethical governance is an ongoing responsibility shared by developers, providers, governments, and affected people. Evidence of benefit and harm should inform revisions. Include feedback from affected communities and evaluate outcomes after system changes.

現実世界の実装

A health ministry includes clinicians and patient groups in AI governance planning.

A hospital establishes a way to report and investigate algorithm-related harm.

A developer documents data limits and evaluates performance in intended settings.

A public agency checks whether AI access benefits groups equitably.

リスクとガードレール

  • 能力が複雑になる一方で、実存的なリスクを SF として扱います。

  • 高度な自律性の下での調整による表面製品の安全性を混乱させる。

  • 英語以外や専門家ではない聴衆には、低品質の情報源しか提供されません。

実装ロードマップ

  1. 製品の危害、誤使用、制御不能/調整不良のリスクを分離します。

  2. どのような証拠がタイムラインと重大度についてのあなたの見方を変えるかを尋ねてください。

  3. マーケティング上の主張よりも、一次情報源と具体的な評価を優先します。

  4. 意識だけでなく、キャリア、政策、資金、スキルなど、行動経路を 1 つ特定します。

探検を続けましょう

Free newsletter

Get the daily AI briefing

Three verified AI stories every weekday morning, written in plain English. Free forever, no ads.

One email each weekday. Unsubscribe in one click. We never sell or share your address.

Test yourself

Take the WHO Guidance on AI in Health quiz

Instant feedback on every answer, and a shareable certificate with a verifiable ID once you pass a course.

クイズを開始する

Support free AI education. AI Understanding is a 501(c)(3) nonprofit — no ads, no paywall, ever. Make a donation

よくある質問

What is WHO Guidance on AI in Health?

WHO guidance on AI in health emphasizes human rights, safety, transparency, accountability, inclusion, and ongoing evaluation. These are governance principles, not a product certification or a substitute for local law. Health systems should involve affected people, assess risks through the lifecycle, and ensure that AI supports rather than displaces human decision-making.

What does WHO’s AI-in-health guidance provide?

WHO guidance sets principles and recommendations, not product certification.

Is WHO guidance a product certification?

The guide distinguishes ethical principles from legal authorization.

Which disclosure most directly explains a health AI tool’s intended use, evidence, and limitations?

Transparency should help people understand the system and its use.

Who shares responsibility for ethical AI in health?

WHO frames governance as a shared stakeholder responsibility.